MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 296 filers reported holding MEDICINES CO in Q4 2019. The put-call ratio across all filers is 0.95 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $70,000,000 | +91.9% | 1,400,000 | +40.0% | 2.81% | +90.3% |
| Q2 2019 | $36,470,000 | +86.4% | 1,000,000 | +42.9% | 1.48% | +84.6% |
| Q1 2019 | $19,565,000 | +2.2% | 700,000 | -30.0% | 0.80% | +12.7% |
| Q4 2018 | $19,140,000 | -36.0% | 1,000,000 | 0.0% | 0.71% | -8.9% |
| Q3 2018 | $29,910,000 | -25.9% | 1,000,000 | -9.1% | 0.78% | -9.3% |
| Q2 2018 | $40,370,000 | +36.2% | 1,100,000 | +22.2% | 0.86% | +131.3% |
| Q1 2018 | $29,646,000 | +20.5% | 900,000 | 0.0% | 0.37% | 0.0% |
| Q4 2017 | $24,606,000 | +32.9% | 900,000 | +80.0% | 0.37% | +16.3% |
| Q3 2017 | $18,520,000 | -11.4% | 500,000 | -9.1% | 0.32% | -12.6% |
| Q2 2017 | $20,906,000 | +327.5% | 550,000 | +450.0% | 0.36% | +234.9% |
| Q1 2017 | $4,890,000 | +188.2% | 100,000 | +100.0% | 0.11% | +186.8% |
| Q4 2016 | $1,697,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $356,917,000 | 29.62% |
| SYQUANT CAPITAL SAS | 505,030 | $42,897,000 | 22.09% |
| Moab Capital Partners | 521,987 | $44,338,000 | 17.51% |
| Antipodean Advisors LLC | 321,000 | $27,266,000 | 15.60% |
| RAMIUS ADVISORS LLC | 419,826 | $35,660,000 | 15.34% |
| DLD Asset Management, LP | 3,275,900 | $278,255,000 | 15.00% |
| Foresite Capital Management IV, LLC | 403,217 | $34,249,000 | 14.78% |
| WHITE SQUARE CAPITAL LLP | 239,331 | $20,329,000 | 14.70% |
| Davide Leone & Partners Investment Co Ltd. | 1,146,192 | $97,358,000 | 12.50% |
| Quad Capital Management Advisors LLC | 8,640 | $734,000 | 11.19% |